Medical Aerosol Product Supply – Albuterol Sulfate Inhalation Aerosol

The contract establishes a subcontract for the supply of FDA-approved albuterol sulfate inhalation aerosol, requiring each unit to deliver precisely 108 mcg per actuation in an 8.5 gram canister with exactly 200 actuations per unit, fully compliant with the National Drug Code and NSN 6505015436562. The product must meet all regulatory and technical specifications to ensure consistent performance and safety for military medical use. The solicitation, issued under NAICS code 325412 by the Department of Defense through the Medical Supply Chain Pharm FSA, targets qualified vendors to fulfill a critical readiness requirement for respiratory care across deployment locations. Responses are due by July 27, 2026, with performance expected to support operations at Fort Bragg, North Carolina. The requirement is not subject to any specific set-aside classification, and all proposals must align with the technical standards and procurement guidelines established by the Department of Defense’s Defense Logistics Agency. Bidders must demonstrate proven capacity to deliver compliant, high-quality inhalers on schedule to maintain operational medical readiness. Further details and submission protocols are accessible through the official DIBBS platform link provided in the solicitation.